Anavex Life Sciences Corp. (AVXL) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Anavex Life Sciences Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.634 -- 00:00:06.762 Good morning, everyone, and welcome to the Anovex Life Sciences Fiscal 2025 First Quarter 00:00:06.762 -- 00:00:11.550 Conference Call. My name is Clint Tomlinson, and I will be your host for today's call. 00:00:11.550 -- 00:00:15.216 At this time, all participants are in a listen-only mode, and later we will conduct a 00:00:15.216 -- 00:00:19.022 question-and-answer session. During this session, if you would like to ask a question, 00:00:19.022 -- 00:00:23.229 please use the Q&A box or raise your hand. 00:00:23.229 -- 00:00:26.103 Note that this conference is being recorded. 00:00:26.103 -- 00:00:31.787 The call will be available for replay on Anavex's website at www.anavex.com. 00:00:33.450 -- 00:00:37.934 With us today is Dr. Christopher Misling, President and Chief Executive Officer, and 00:00:37.934 -- 00:00:41.317 Sondra Burnish, Principal Financial Officer. 00:00:41.317 -- 00:00:46.082 Before we begin, please note that this conference call, the company will make some projections 00:00:46.082 -- 00:00:50.346 and forward-looking statements. These statements are only predictions based on current 00:00:50.346 -- 00:00:54.605 information and expectations and involve a number of risks and uncertainties. 00:00:54.605 -- 00:00:58.151 We encourage you to review the company's filings with the SEC. 00:00:58.151 -- 00:01:03.421 This includes, without limitation, the company's forms 10-K and 10-Q, which identify 00:01:03.421 -- 00:01:08.129 the specific factors that may cause actual results or events to differ materially from 00:01:08.129 -- 00:01:10.906 those described in these forward-looking statements. 00:01:10.906 -- 00:01:15.613 These factors may include, without limitation, risks inherent in the development and 00:01:15.613 -- 00:...